DOP056. Pharmacokinetics and exposure-response relationships of golimumab in paediatric patients with moderate-to-severe ulcerative colitis: results from a multicentre open-label study | Zendy

AI Assistant Blog Pricing

DOP056. Pharmacokinetics and exposure-response relationships of golimumab in paediatric patients with moderate-to-severe ulcerative colitis: results from a multicentre open-label study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.